Advanced search
Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 19, 2006 - Issue 3
Submit an article Journal homepage
4,891
Views
85
CrossRef citations to date
0
Altmetric
Articles

Structure-Function Relations of Human Hemoglobins

Alain J. Marengo-Rowe
, MD
Pages 239-245 | Published online: 11 Dec 2017

  • Perutz MF, Rossmann MG, Cullis MG, Muirhead H, Will G, North ACT. Structure of haemoglobin. A three-dimensional Fourier synthesis at 5.5Å resolution, obtained by X-ray analysis. Nature 1960;185: 416–422.
  • Ingram VM. Gene mutations in human haemoglobin: the chemical difference between normal and sickle cell haemoglobin. Nature 1957;180: 326–328.
  • Allison AC. Protection afforded by sickle-cell trait against subtertian malarial infection. Br Med J 1954;1: 290–294.
  • Perutz MF, Lehmann H. Molecular pathology of human haemoglobin. Nature 1968;219 (157): 902–909.
  • Marengo-Rowe A. Haemoglobinopathies. Br J Hosp Med 1971;6: 617–630.
  • Perutz MF. Proteins and Nucleic Acids: Structure and Function. Amsterdam: Elsevier, 1962: 35–48.
  • Konotey-Ahulu FID. Hereditary qualitative and quantitative erythrocyte defects in Ghana. An historical and geographical survey. Ghana Med J 1968;7: 118–119.
  • Herrick JB. Peculiar elongated and sickle-shaped red corpuscles in a case of severe anemia. Arch Intern Med 1910;6: 517.
  • Bunn HF. Pathogenesis and treatment of sickle cell disease. N Engl J Med 1997;337 (11): 762–769.
  • Raphael RI. Pathophysiology and treatment of sickle cell disease. Clin Adv Hematol Oncol 2005;3 (6): 492–505.
  • Pauling L, Itano HA, Singer SJ, Wells IC. Sickle cell anemia, a molecular disease. Science 1949;110: 543–548.
  • Nagel RL, Platt OS. General pathophysiology of sickle cell anemia. In Steinberg MH, Forget BG, Higgs DR, eds. Disorders of Hemoglobin. Cambridge: Cambridge University Press, 2001: 494–526.
  • Pathare A, Kindi SA, Daar S, Dennison D. Cytokines in sickle cell disease. Hematology 2003;8 (5): 329–337.
  • Hebbel RP, Mohandas N. Cell adhesion and microrheology in sickle-cell disease. In Steinberg MH, Forget BG, Higgs DR, eds. Disorders of Hemoglobin. Cambridge: Cambridge University Press, 2001: 527–549.
  • Adams RJ, Brambilla D; Optimizing Primary Stroke Prevention in Sickle Cell Anemia (STOP 2) Trial Investigators. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med 2005;353 (26): 2769–2778.
  • Marengo-Rowe AJ, Beale D, Lehmann H. New human haemoglobin variant from southern Arabia: G-Audhali (alpha-23B4 glutamic acid→valine) and the variability of B4 in human haemoglobin. Nature 1968;219 (159): 1164–1166.
  • Perutz RR, Ligouri AM, Eirich F. X-ray and solubility studies of the haemoglobin of sickle-cell anaemia patients. Nature 1951;167 (4258): 929–931.
  • Ballas SK, Smith ED. Red blood cell changes during the evolution of the sickle cell painful crisis. Blood 1992;79 (8): 2154–2163.
  • Vichinsky EP. Comprehensive care in sickle cell disease: its impact on morbidity and mortality. Semin Hematol 1991;28 (3): 220–226.
  • National Heart, Lung, and Blood Institute, National Institutes of Health. The Management of Sickle Cell Disease (NIH Publication No. 02-2117). Bethesda, MD: NIH, 2002. Available at http://www.nhlbi.nih.gov/health/prof/blood/sickle/; accessed February 13, 2006.
  • Vermylen C, Cornu G. Hematopoietic stem cell transplantation for sickle cell anemia. Curr Opin Hematol 1997;4 (6): 377–380.
  • Steinberg MH, Barton F, Castro O, Pegelow CH, Ballas SK, Kutlar A, Orringer E, Bellevue R, Olivieri N, Eckman J, Varma M, Ramirez G, Adler B, Smith W, Carlos T, Ataga K, DeCastro L, Bigelow C, Saunthararajah Y, Telfer M, Vichinsky E, Claster S, Shurin S, Bridges K, Waclawiw M, Bonds D, Terrin M. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA 2003;289 (13): 1645–1651.
  • Cokic VP, Smith RD, Beleslin-Cokic BB, Njoroge JM, Miller JL, Gladwin MT, Schechter AN. Hydroxyurea induces fetal hemoglobin by the nitric oxide–dependent activation of soluble guanylyl cyclase. J Clin Invest 2003;111 (2): 231–239.
  • Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994;330 (23): 1639–1644.
  • Udani M, Zen Q, Cottman M, Leonard N, Jefferson S, Daymont C, Truskey G. Basal cell adhesion molecule/Lutheran protein. The receptor critical for sickle cell adhesion to laminin. J Clin Invest 1998;101 (11): 2550–2558.
  • Ataga KI, Orringer EP. Hypercoagulability in sickle cell disease: a curious paradox. Am J Med 2003;115 (9): 721–728.
  • Westwick J, Watson-Williams EJ, Krishnamurthi S, Marks G, Ellis V, Scully MF, White JM, Kakkar VV. Platelet activation during steady state sickle cell disease. J Med 1983;14 (1): 17–36.
  • Westerman MP, Green D, Gilman-Sachs A, Beaman K, Freels S, Boggio L, Allen S, Zuckerman L, Schlegel R, Williamson P. Antiphospholipid antibodies, proteins C and S, and coagulation changes in sickle cell disease. J Lab Clin Med 1999;134 (4): 352–362.
  • Francis RB Jr. Platelets, coagulation, and fibrinolysis in sickle cell disease: their possible role in vascular occlusion. Blood Coagul Fibrinolysis 1991;2 (2): 341–353.
  • Perutz MF. Stereochemistry of cooperative effects in haemoglobin. Nature 1970;228 (5273): 726–739.
  • Perutz MF, Wilkinson AJ, Paoli M, Dodson GG. The stereochemical mechanism of the cooperative effects in hemoglobin revisited. Annu Rev Biophys Biomol Struct 1998;27: 1–34.
  • Charache S, Weatherall DJ, Clegg JB. Polycythemia associated with a hemoglobinopathy J Clin Invest 1966;45 (6): 813–822.
  • Botha MC, Beale D, Isaacs WA, Lehmann H. Hemoglobin J Cape Town-alpha-2 92 arginine replaced by glutamine beta-2. Nature 1966;212 (64): 792–795.
  • Jones RT, Osgood EE, Brimhall B, Koler RD. Hemoglobin Yakina. I. Clinical and biochemical studies. J Clin Invest 1967;46 (11): 1840–1847.
  • Lokich JJ, Moloney WC, Bunn HF, Bruckheimer SM, Ranney HM. Hemoglobin Brigham (α2Aβ2100Pro→Leu). Hemoglobin variant associated with familial erythrocytosis. J Clin Invest 1973;52 (8): 2060–2067.
  • Adamson JW, Parer JT, Stamatoyannopoulos G. Erythrocytosis associated with hemoglobin Rainier: oxygen equilibria and marrow regulation. J Clin Invest 1969;48 (8): 1376–1386.
  • Bunn HF, Bradley TB, Davis WE, Drysdale JW, Burke JF, Beck WS, Layer MB. Structural and functional studies on hemoglobin Bethesda (α2A β2145His), a variant associated with compensatory erythrocytosis. J Clin Invest 1972;51 (9): 2299–2309.
  • Jensen M, Oski FA, Nathan DG, Bunn HF. Hemoglobin Syracuse A (α2A β2143(H21)His→Pro), a new high-affinity variant detected by special electrophoretic methods. Observations on the auto-oxidation of normal and variant hemoglobins. J Clin Invest 1975;55 (3): 469–477.
  • Reissmann KR, Ruth WE, Nomura T. A human hemoglobin with lowered oxygen affinity and impaired heme-heme interactions. J Clin Invest 1961;40: 1826–1833.
  • Imamura T, Fujita S, Ohta Y, Hanada M, Yanase T. Hemoglobin Yoshizuka (G10(108)β asparagine→aspartic acid): a new variant with a reduced oxygen affinity from a Japanese family. J Clin Invest 1969;48 (12): 2341–2348.
  • Imai K, Morimoto H, Kotani M, Shibata S, Miyaji T. Studies on the function of abnormal hemoglobins. II. Oxygen equilibrium of abnormal hemoglobins: Shimonoseki, Ube II, Hikari, Gifu, and Agenogi. Biochim Biophys Acta 1970;200 (2): 197–202.
  • Carrell RW, Lehmann H, Hutchinson HE. Hemoglobin Koln (β-98 valine→methionine): an unstable protein causing inclusion-body anaemia. Nature 1966;210 (39): 915–916.
  • Dacie JV, Shinton NK, Gaffney PJ Jr, Lehmann H. Haemoglobin Hammersmith (beta-42 (CDI) Phe replaced by Ser). Nature 1967;216 (5116): 663–665.
  • Sakuragawa M, Ohba Y, Miyaji T, Yamamoto K, Miwa S. A Japanese boy with hemolytic anemia due to an unstable hemoglobin (Hb Bristol). Nippon Ketsueki Gakkai Zasshi 1984;47 (4): 896–902.
  • Murari J, Smith LL, Wilson JB, Schneider RG, Huisman TH. Some properties of hemoglobin Gun Hill. Hemoglobin 1977;1 (3): 267–282.
  • Plaseska D, Dimovski AJ, Wilson JB, Webber BB, Hume HA, Huisman TH. Hemoglobin Montreal: a new variant with an extended beta chain due to a deletion of Asp, Gly, Leu at positions 73, 74, and 75, and an insertion of Ala, Arg, Cys, Gln at the same location. Blood 1991;77 (1): 178–181.
  • Winterbourn CC, Carrell RW. Studies of hemoglobin denaturation and Heinz body formation in the unstable hemoglobins. J Clin Invest 1974;54 (3): 678–689.
  • Cathie IAB. Apparent idiopathic Heinz body anaemia. Great Ormond Street J 1952;2: 43–48.
  • Hörlein H, Weber G. Über Chronishce Familiare Metthämoglobinamie und Eine Modificazation des Methämoglobins. Dtsch Med Wochenschr 1948;73: 476.
  • Gerald PS, Efron ML. Chemical studies of several varieties of Hb M. Proc Natl Acad Sci U S A 1961;47: 1758–1767.
  • Stavem P, Stromme J, Lorkin PA, Lehmann H. Haemoglobin M Saskatoon with slight constant haemolysis, markedly increased by sulphonamides. Scand J Haematol 1972;9 (6): 566–571.
  • Hayashi N, Motokawa Y, Kikuchi G. Studies on relationships between structure and function of hemoglobin M-Iwate. J Biol Chem 1966;241 (1): 79–84.
  • Hutt PJ, Pisciotta AV, Fairbanks VF, Thibodeau SN, Green MM. DNA sequence analysis proves Hb M-Milwaukee-2 is due to beta-globin gene codon 92 (CAC→TAC), the presumed mutation of Hb M-Hyde Park and Hb M-Akita. Hemoglobin 1998;22 (1): 1–10.
  • Ham RD, Chitayat D, Cooper R, Bandler E, Eng B, Chui DH, Waye JS, Freedman MH. Hb FM-Fort Ripley: confirmation of autosomal dominant inheritance and diagnosis by PCR and direct nucleotide sequencing. Hum Mutat 1994;3 (3): 239–242.
  • Bauer C, Forster M, Gros G, Mosca A, Perrella M, Rollema HS, Vogel D. Analysis of bicarbonate binding to crocodilian hemoglobin. J Biol Chem 1981;256 (16): 8429–8435.
  • Komiyama NH, Miyazaki G, Tame J, Nagai K. Transplanting a unique allosteric effect from crocodile into human haemoglobin. Nature 1995;373 (6511): 244–246.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.